UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033849
Receipt number R000037895
Scientific Title A feasibility open trial of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics
Date of disclosure of the study information 2018/10/01
Last modified on 2020/02/20 18:56:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A feasibility open trial of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics

Acronym

A feasibility study to encourage uptake of cancer screening for people with schizophrenia

Scientific Title

A feasibility open trial of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics

Scientific Title:Acronym

A feasibility study to encourage uptake of cancer screening for people with schizophrenia

Region

Japan


Condition

Condition

Schizophrenia
(including Schizoaffective disorder)

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate the feasibility and preliminary efficacy of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics.

Basic objectives2

Others

Basic objectives -Others

Feasibility

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The proportion of the participants who completed the intervention

Key secondary outcomes

Description about the intervention implemented for each participant

Description about issue in implementing the intervention

Self-reported uptake of colorectal cancer screening and other cancer screenings which are recommended for participants

Municipal records of uptake of colorectal cancer screening and other cancer screenings which are recommended for participants

Description about reasons of uptake or non-uptake of colorectal cancer screening and detailed examination recommended after screening


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Case management to encourage uptake of cancer screening

Usual cancer screening promotion conducted in community setting by Okayama city

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Outpatients diagnosed with schizophrenia or schizoaffective disorder according to the DSM-5 criteria by their primary psychiatrist

2) Patients who visited the hospital of the study site twice or more in the last 6 months

3) Patients aged 40 years or more

4) Patients who live in Okayama city and who are enrolled in the National Health Insurance or Public Assistance systems

5) Patients who understand and agree with the enrollment of this study with IC form, or patients whose proxies consents to their participation in the study

Key exclusion criteria

1) Patients with a history of colorectal cancer

2) Patients who have already received colorectal cancer screening in the 2018 fiscal year

3) Patients who plan to move out of Okayama city within 6 months

4) Patients who are judged by their primary psychiatrists as having a risk to deteriorate their symptoms by participating the study

5) Patients who are judged as having insufficient ability to judge by their primary psychiatrist, and who are not accompanied by their proxies in visiting clinics

6) Patients who are judged as not appropriate for participation by the research director and research investigators

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Norihito Yamada

Organization

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science

Division name

Department of Neuropsychiatry

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

TEL

086-235-7246

Email

nyamada@okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masaki Fujiwara

Organization

Okayama University Hospital

Division name

Department of Neuropsychiatry

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

TEL

086-235-7246

Homepage URL


Email

mfujiwara@okayama-u.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山県精神科医療センター(岡山県)
慈圭病院(岡山県)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

13

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 21 Day

Date of IRB

2018 Year 09 Month 18 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 21 Day

Last modified on

2020 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037895


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name